SMAD9 and glioma: Stratification of gliomas according to the latest WHO 2021 classification revealed elevated SMAD9 mRNA levels in IDH-wildtype glioblastoma compared to both IDH-mutant astrocytomas and oligodendrogliomas (Fig. 2b).